Patent · US Active

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

US9060941B2 · kind B2 · utility

0Cited by

72References

4Claims

0Family size

Assignees

Actavis, Inc. · US
Takeda Pharmaceutical Company Limited · JP

Inventors

Unchalee Lodin · Surfside, US
Jack Cardinal · Sunrise, US
Avinash Nangia · Weston, US
Kazuhiro Okochi · Osaka, JP

Key dates

Filing date	Mar 30, 2005
Grant date	Jun 23, 2015
Priority date	—
Expiry date	Sep 20, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.